Llitjos, Jean-Francois
Carrol, Enitan D.
Osuchowski, Marcin F.
Bonneville, Marc
Scicluna, Brendon P.
Payen, Didier
Randolph, Adrienne G.
Witte, Stephan
Rodriguez-Manzano, Jesus
François, Bruno
,
Funding for this research was provided by:
Institut Merieux, France
Article History
Received: 3 May 2024
Accepted: 10 July 2024
First Online: 13 July 2024
Declarations
:
: Not applicable.
: Not applicable.
: EDC declares being a previous member of National Institute for Health and Care Excellence (NICE) Sepsis Guideline Development Group, and a current member of Surviving Sepsis Campaign Pediatrics Guideline panel and Society of Critical Care Medicine Paediatric Sepsis Definition Task Force. She also declares NIHR-funded research collaboration with Biomerieux, and research funding from National Institute of Health and Care Research (NIHR) and H2020. MB is currently working for Institut Merieux, a holding with bioMérieux as one of its companies. AGR has received consulting fees from Inotrem and Thermo Fisher for work related to sepsis biomarkers, and is the Chair of the International Sepsis Forum which is funded by industry. BF has received consulting fees from AM-Pharma, Inotrem, Aridis and Enlivex outside the submitted work. The other authors have no conflict of interests to declare.